Metropolitan Police Warns FiveYear Delay Looms for Post Office Horizon Inquiry Without Extra Funding Nationwide Faces Governance Concerns as Labour MP Raises Issues Before AGM Prediction Markets Face Regulatory Turmoil as 16 States Pursue Legal Actions CVS to Cover Eli Lillys GLP1 Drugs Broadening Access for Millions Consumer Sentiment Slides to Fresh Record Low in May as Iran Conflict Fuels Inflation Concerns How TVKs Startup Approach Disrupted Tamil Nadu Politics An Analysis Similarweb Q1 2026 Earnings EPS Slightly Below Estimates but Shares Rally on Strategic Momentum ACGL Q1 2026 Earnings Slight EPS Miss Highlights Strong Underwriting Amid Market Headwinds OWLT Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise Despite Stock Decline TransUnion Q1 2026 Earnings EPS Surges Past Estimates Shares Edge Higher CLW Q1 2026 Earnings EPS Beats Estimates Despite Negative Earnings Stock Edges Lower WTFCN Q1 2026 Earnings Preferred Stocks Underlying EPS Surprises to the Upside Kelly Services KELYA Advances 222 Approaching Key Resistance After Support Hold Northern Technologies International NTIC Holds Steady at 80 Key Support Test in Focus Research Solutions Inc RSSS Tests Key Support Zone After Modest Decline Amplitude Inc AMPL Shows Modest Gains as Price Holds Above Key Support ClevelandCliffs CLF Surges Over 5 as Steel Stock Rebounds Toward Resistance Telecom Argentina TEO Q1 2026 Earnings Massive EPS Surprise Drives Positive Market Response IDXX Q1 2026 Earnings Modest EPS Beat Amid Flat Revenue Backdrop Tvardi Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as pipeline advances Tesla Launches Full SelfDriving Supervised in China Amid Intensifying Competition from Local EV Rivals One Stop Systems OSS Q1 2026 Earnings Surprise Profit Beats Expectations Stock Rises 523 Barclays Raises Price Target on JFrog to 75 Maintains Overweight Rating Pakistan to Deploy Paramilitary Force to Secure CopperGold Mining Region Marvell Technology Q1 2026 Earnings Slight EPS Miss Overshadowed by Positive Stock Reaction Immix Biopharma IMMX Edges Lower in Consolidation Phase Eyes Key Support at 829